WebJul 31, 2013 · Harold Margolis, Jorge L. Muñoz-Jordán Correction: Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus Gilberto A. Santiago, Edgardo Vergne, Yashira Quiles, Joan Cosme, Jesus Vazquez, Juan F. Medina, Freddy Medina, Candimar Colón, Harold Margolis, Jorge L. Muñoz … WebPlenary: State of the art disease surveillance (H. Margolis) Plenary: State of the art vector surveillance (S. Ritchie) Plenary: Key issues that could affect surveillance results for an integrated disease and vector surveillance system in a country where an integrated control program has been initiated.
Clinical characteristics of a large cohort of US participants enrolled ...
Webkinson, MD, MPH, and Harold S. Margolis, MD, of the Centers for Disease Control and Prevention for answering the following questions for our readers. Drs. Atkinson and Margolis serve as CDC liaisons to the Coalition. • Dr. Atkinson, medical epidemiologist at the Na-tional Immunization Program, conducts train-ing workshops via satellite across ... WebJul 13, 2010 · “We’re concerned that if dengue gains a foothold in Key West, it will travel to other southern cities where the mosquito that transmits dengue is present, like Miami,” said Harold Margolis ... rps fandom
Harold Margolis - CDC ZoomInfo
WebMargolis began his 34-year medical career at the Centers for Disease Control (CDC), first serving in Alaska. He relocated to Phoenix, Arizona, serving in the CDC Hepatitis Branch. WebNov 27, 2001 · This "ring vaccination" strategy is what succeeded in eradicating the disease in the 1970s, the CDC's Harold Margolis, MD, told reporters during a telephone briefing Monday. He explained, "At the heart of this plan is ring vaccination or what is sometimes called search and containment—that is, identifying infected individuals and locating ... WebHarold Margolis, CDC; Morgan Marks, Merck and Co. Inc; Federico Narvaez, Hospital Infantil Manuel de Jesus Rivera; Van Vinh Chau Nguyen, Hospital for Tropical Diseases; Fernando Noriega, Sanofi Pasteur; Alexander Precioso, Instituto Butantan; Elsa Rojas, Universidad Industrial de Santander; rps ey